Original research
par
Bachireddy, Chethan te al
Date de publication
2021
Géographie
Kyrgyzstan
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
In Kyrgyzstan, an estimated 35% of people in prison are PWID, and 10% have been diagnosed with HIV. In 2008, Kyrgyzstan became the first country in EECA to provide free and voluntary methadone in prisons. We examine the impact of this national program on methadone within prison as well as linkage to and retention in treatment upon release to the community.
Constatations/points à retenir
In the first 10 years (2008–2018), 982 individuals initiated within-prison methadone, an estimated 36.8% of all incarcerated people who inject drugs. Of 645 individuals who initiated within-prison methadone and were released, 19.8% (128) linked to community methadone – 61.9% within 7 days of release. Of those who linked to community methadone upon release, 14.8% remained in care for at least 12 months. As compared to people who initiated and then discontinued methadone during incarceration, those who continued to receive methadone through the time of release were 20x more likely to link to community methadone.
La conception ou méthodologie de recherche
We examined the delivery of methadone services, including the duration of treatment both within prison and after release, for all prisoners who were prescribed methadone in Kyrgyz prisons from 2008 to 2018. Reasons for discontinuing methadone, HIV status and methadone dose are also analyzed.
Mots clés
About PWUD
Outcomes
Legal system/law enforcement
Substitution/OAT
